Document is current
Any future updates will be listed below
-
Authors
Geng, Fenghao
Chen, Jianhui
Song, Bin
Tang, Zhicheng
Li, Xiaoqian
Zhang, Shuaijun
Yang, Tingyi
Liu, Yulan
Mo, Wei
Zhang, Yining
Sun, Chuntang
Tan, Lei
Tu, Wenling
Yu, Daojiang
Cao, Jianping
Zhang, Shuyu https://orcid.org/0000-0003-1419-3635
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82073477, 32071238, 82203973)
- License Information
-
More Information
Article History
Received: 7 November 2023
Accepted: 13 May 2024
First Online: 7 June 2024
Competing interests
: West China Second University Hospital has two patents pending related to the two effective IRF1-responsive inhibitors reported in this work, entitled “A small molecular compound against IRF1-responsive for treating inflammatory skin injury” and “A novel agent against genotoxic-induced tissue injuries”, respectively.
